Articles / Product Explainer – Calcipotriol and betamethasone dipropionate foam spray for the topical treatment of psoriasis vulgaris in adults
0 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
These are activities that require reflection on feedback about your work.
These are activities that use your work data to ensure quality results.
Dr Linda Calabresi: Hello and welcome to this Healthed Product Explainer podcast. I’m Dr. Linda Calabresi and I’m a GP and the medical editor of Healthed. The product explainers feature leading experts describing their own views on products, devices and related developments and why they are relevant to general practice. We thank the industry for supporting the development of this useful resource and we hope you find it a helpful addition to your practice.
In this episode, dermatologist Dr. Ryan De Cruz explains the role of calcipotriol and betamethasone dipropionate foam spray for the topical treatment of psoriasis vulgaris in adults. Dr De Cruz is a specialist dermatologist and the Head of the Bone Marrow Transplant Dermatology Clinic at the Royal Melbourne Hospital. He’s also the founder of Southern Dermatology.
This product explainer is supported by Leo Pharma.
RSV Prevention in Infants and Pregnant Women
STIs – Common and Tricky Cases
Role of Testosterone During Menopause - Evidence vs Hype
Vision and Driving Fitness: Key Insights for Health Practitioners
Yes
No
Listen to expert interviews.
Click to open in a new tab
Browse the latest articles from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.
Menopause and MHT
Multiple sclerosis vs antibody disease
Using SGLT2 to reduce cardiovascular death in T2D
Peripheral arterial disease